The FDA has granted Siemens Healthineers clearance for its syngo.via VB30 molecular imaging system, which enables 3D disease visualization through its new PET/CT and SPECT/CT hybrid volume-rendering technique, as well as four system features available on its Biograph mCT PET/CT systems: CardioFreeze, OncoFreeze, FlowMotion Multiparametric PET Suite and QualityGuard. The offerings will be featured at the SNMMI Annual Meeting.
Siemens' molecular imaging software, PET/CT system features OK'd by FDA
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.